Results for “ ”

Entry Author Date Location
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Moderna CMO Talks COVID-19 Vaccine at Xcelerate Next Week 09/16/20 Boston
Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy 09/15/20 Europe
Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals 09/14/20 Seattle
Xconomy Awards On-Demand ‘Meet the Finalists’ Webcast Series Continues This Week 09/14/20 Boston
Gilead Adds “Cornerstone” Cancer Drug in $21B Immunomedics Buyout 09/14/20 San Francisco
Join Xconomy Next Week at the Virtual Xcelerate Keynote Series at Biotech Week Boston 09/14/20 Boston
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Reeling From FDA Rejection, Intercept Pharma Slashes Headcount by 25% 09/01/20 New York
Early Bird Sale for Xcelerate at Biotech Week Boston Ends This Friday 08/31/20 Boston
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Athira Aims for the Nasdaq to Advance Alzheimer’s Drug to Phase 2 Tests 08/27/20 Seattle
AbbVie & UroGen Overactive Bladder Treatment Misses in Phase 2 Trial 08/27/20 New York
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases 08/26/20 Boston
FDA Adds Plasma as 2nd COVID-19 Treatment Under Emergency Guidelines 08/24/20 National
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
J&J Boosts Autoimmune Disease Drug Pipeline With $6.5B Momenta Buyout 08/19/20 New York
Bristol Myers Squibb to Splash Out $475M on Dragonfly Immunotherapy 08/17/20 New York
Advisory Body Backs MesoBlast Therapy for Transplant Complication 08/14/20 New York
CureVac’s IPO Hauls In $213M as Key mRNA COVID-19 Vaccine Test Nears 08/14/20 Europe
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
With FDA Nod, NS Pharma Duchenne Drug Becomes Sarepta Competitor 08/12/20 New York
Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia 08/12/20 San Francisco
F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections 08/12/20 Europe
Pfizer’s Bourla: There’s Coronavirus Vaccine Pressure, But It’s Not Political 08/12/20 National
Bayer Boosts Women’s Health Drug Pipeline, Paying $425M for KaNDy 08/11/20 Europe
Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More 08/07/20 National
As Patients Pivot to Telehealth, Teladoc & Livongo Plan $18.5B Tie-Up 08/05/20 New York
Still Stuck on Adhesion Issues, FDA Rejects DBV’s Peanut Allergy Patch 08/04/20 National
Page 1 of 299 next page »